Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 29 matching records.
29 results — page 1 of 2
- Level CCase Report / SeriesPubMed
Management of Complex Perianal Fistulas Using Platelet-Rich Plasma and Adipose-Derived Mesenchymal Stem Cells: A Case Series.
Case Report / Series on Autoimmune Research, published in Cureus (2025) — summary generated from the PubMed abstract.
- 2025
Cureus2 citations - Level AMeta-analysisPubMed
Efficacy of mesenchymal stem cell-based therapies in the treatment of perianal fistulizing Crohn's disease: a systematic review and meta-analysis.
Meta-analysis with a reported sample of 596 on Autoimmune Research, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.
- 2025
- n = 596
Stem Cell Res Ther6 citations - Level CProspective StudyPubMed
Predictive Factors of Autologous Bone Marrow-Derived Mesenchymal Stem Cell Therapy's Success in the Treatment of Perianal Fistulas in Patients With Crohn's Disease.
Prospective Study on Autoimmune Research, published in Cureus (2025) — summary generated from the PubMed abstract.
- 2025
Cureus - Level CProspective StudyPubMed
Perianal fistulas: a new management approach using mesenchymal stem cells as a human, biological and autologous tool-a single-centre observational study.
Prospective Study with a reported sample of 63 on Autoimmune Research, published in Int J Colorectal Dis (2025) — summary generated from the PubMed abstract.
- 2025
- n = 63
Int J Colorectal Dis - Level CProspective StudyPubMed
[A new treatment option for complex perianal fistulas in Crohn's disease patients; development of darvadstrocel (allogeneic expanded adipose-derived mesenchymal stem cells) in Japan].
Prospective Study on Chronic Inflammation, Immune Modulation, Autoimmune Research, published in Nihon Yakurigaku Zasshi (2024) — summary generated from the PubMed abstract.
- 2024
Nihon Yakurigaku Zasshi - Level CCase Report / SeriesEurope PMC
Mesenchymal stem cell therapy for therapy refractory complex Crohn's perianal fistulas: a case series
Case Report / Series with a reported sample of 30 on Autoimmune Research, published in Stem Cell Res Ther (2024) — summary generated from the PubMed abstract.
- 2024
- n = 30
Stem Cell Res Ther7 citations - Level CCohort StudyPubMed
Real-life effectiveness of allogeneic expanded adipose-derived mesenchymal stem cell therapy for perianal fistulizing refractory Crohn's disease.
Cohort Study with a reported sample of 36 on Scar, Autoimmune Research, published in Clin Res Hepatol Gastroenterol (2024) — summary generated from the PubMed abstract.
- 2024
- n = 36
Clin Res Hepatol Gastroenterol - Level BClinical TrialPubMed
In Situ Treatment of Refractory Perianal Fistulas in Dogs with Low-Dose Allogeneic Adipose-Derived Mesenchymal Stem Cells.
Clinical Trial on Autoimmune Research, published in Animals (Basel) (2024) — summary generated from the PubMed abstract.
- 2024
Animals (Basel)2 citations - Level AMeta-analysisEurope PMC
Long-term efficacy of mesenchymal stem cell treatment for complex perianal fistulas: A systematic review and meta-analysis
Meta-analysis on Chronic Inflammation, Immune Modulation, Autoimmune Research, published in Cent Eur J Immunol (2024) — summary generated from the PubMed abstract.
- 2024
Cent Eur J Immunol2 citations - Level DAnimal StudyEurope PMC
Exosomes derived from umbilical cord mesenchymal stem cells promote healing of complex perianal fistulas in rats
Animal Study on Chronic Wound, Autoimmune Research, published in Stem Cell Res Ther (2024) — summary generated from the PubMed abstract.
- 2024
Stem Cell Res Ther11 citations - Level CProspective StudyPubMed
Clinical and MRI Evolution After Local Injection of Bone Marrow-Derived Mesenchymal Stem Cells in Perianal Fistulae in Crohn's Disease: Results From a Prospective Monocentric Study.
Prospective Study with a reported sample of 16 on Autoimmune Research, published in J Crohns Colitis (2023) — summary generated from the PubMed abstract.
- 2023
- n = 16
J Crohns Colitis - Level AMeta-analysisEurope PMC
Up-to-date meta-analysis of long-term evaluations of mesenchymal stem cell therapy for complex perianal fistula
Meta-analysis on Autoimmune Research, published in World J Stem Cells (2023) — summary generated from the PubMed abstract.
- 2023
World J Stem Cells2 citations - Level BClinical TrialEurope PMC
Efficacy and safety of allogeneic umbilical cord-derived mesenchymal stem cells for the treatment of complex perianal fistula in Crohn's disease: a pilot study
Clinical Trial with a reported sample of 10 on Autoimmune Research, published in Stem Cell Res Ther (2023) — summary generated from the PubMed abstract.
- 2023
- n = 10
Stem Cell Res Ther14 citations - Level BClinical TrialPubMed
The history of Crohn's perianal fistula treatment with mesenchymal stem cells: the story of darvadstrocel.
Clinical Trial on Autoimmune Research, published in Expert Opin Biol Ther (2023) — summary generated from the PubMed abstract.
- 2023
Expert Opin Biol Ther1 citations - Level CProspective StudyPubMed
Mesenchymal stem cell therapy for Crohn's perianal fistula-a real-world experience.
Prospective Study on Autoimmune Research, published in Colorectal Dis (2023) — summary generated from the PubMed abstract.
- 2023
Colorectal Dis9 citations - Level BRandomized Controlled TrialPubMed
Follow-up Study to Evaluate the Long-term Safety and Efficacy of Darvadstrocel (Mesenchymal Stem Cell Treatment) in Patients With Perianal Fistulizing Crohn's Disease: ADMIRE-CD Phase 3 Randomized Controlled Trial.
Randomized Controlled Trial with a reported sample of 25 on Autoimmune Research, published in Dis Colon Rectum (2022) — summary generated from the PubMed abstract.
- 2022
- n = 25
Dis Colon Rectum103 citations - Level CProspective StudyPubMed
[Treatment of perianal fistulas with mesenchymal stem cells].
Prospective Study on Autoimmune Research, published in Ugeskr Laeger (2022) — summary generated from the PubMed abstract.
- 2022
Ugeskr Laeger - Level BClinical TrialPubMed
Durable Response in Patients With Refractory Fistulizing Perianal Crohn's Disease Using Autologous Mesenchymal Stem Cells on a Dissolvable Matrix: Results from the Phase I Stem Cell on Matrix Plug Trial.
Clinical Trial with a reported sample of 20 on Autoimmune Research, published in Dis Colon Rectum (2022) — summary generated from the PubMed abstract.
- 2022
- n = 20
Dis Colon Rectum15 citations - Level BClinical TrialPubMed
Safety of Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells for the Treatment of Complex Perianal Fistulas Not Associated With Crohn's Disease: A Phase I Clinical Trial.
Clinical Trial with a reported sample of 20 on Autoimmune Research, published in Dis Colon Rectum (2021) — summary generated from the PubMed abstract.
- 2021
- n = 20
Dis Colon Rectum - Level BClinical TrialPubMed
Allogeneic expanded adipose-derived mesenchymal stem cell therapy for perianal fistulas in Crohn's disease: A case series.
Clinical Trial with a reported sample of 11 on Immune Modulation, Autoimmune Research, published in Colorectal Dis (2021) — summary generated from the PubMed abstract.
- 2021
- n = 11
Colorectal Dis23 citations - Level BClinical TrialPubMed
Molecular differences of adipose-derived mesenchymal stem cells between non-responders and responders in treatment of transphincteric perianal fistulas.
Clinical Trial with a reported sample of 27 on Autoimmune Research, published in Stem Cell Res Ther (2021) — summary generated from the PubMed abstract.
- 2021
- n = 27
Stem Cell Res Ther6 citations - Level DNarrative ReviewEurope PMC
Current Overview on the Use of Mesenchymal Stem Cells for Perianal Fistula Treatment in Patients with Crohn's Disease
Narrative Review on Autoimmune Research, published in Life (Basel) (2021) — summary generated from the PubMed abstract.
- 2021
Life (Basel)5 citations - Level DNarrative ReviewPubMed
Mesenchymal Stromal Cell Therapy in the Management of Perianal Fistulas in Crohn's Disease: An Up-To-Date Review.
Narrative Review on Immune Modulation, Autoimmune Research, published in Medicina (Kaunas) (2020) — summary generated from the PubMed abstract.
- 2020
Medicina (Kaunas)9 citations - Level AMeta-analysisPubMed
Efficacy and Safety of Mesenchymal Stem Cells in Treatment of Complex Perianal Fistulas: A Meta-Analysis.
Meta-analysis with a reported sample of 730 on Autoimmune Research, published in Stem Cells Int (2020) — summary generated from the PubMed abstract.
- 2020
- n = 730
Stem Cells Int32 citations
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406